News | December 05, 2021
Monthly production capacity of Covishield and Covaxin touches 90% : Govt
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Maharashtra won the award for the highest number of deceased donors transplantations
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The programme will be implemented across 13 states and benefit 256 min
Vakrangee’s distribution network across rural India will help penetrate underserved markets
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Subscribe To Our Newsletter & Stay Updated
